This company has been marked as potentially delisted and may not be actively trading. Reliv' International (RELV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsShort InterestTrendsBuy This Stock RELV vs. IBIO, ETHZ, NBY, AEON, MTNB, OBSV, CPHI, NRBO, GRAY, and AEZSShould you be buying Reliv' International stock or one of its competitors? The main competitors of Reliv' International include iBio (IBIO), Flag Ship Acquisition (ETHZ), NovaBay Pharmaceuticals (NBY), AEON Biopharma (AEON), Matinas Biopharma (MTNB), ObsEva (OBSV), China Pharma (CPHI), NeuroBo Pharmaceuticals (NRBO), Graybug Vision (GRAY), and Aeterna Zentaris (AEZS). Reliv' International vs. Its Competitors iBio Flag Ship Acquisition NovaBay Pharmaceuticals AEON Biopharma Matinas Biopharma ObsEva China Pharma NeuroBo Pharmaceuticals Graybug Vision Aeterna Zentaris Reliv' International (NASDAQ:RELV) and iBio (NYSE:IBIO) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings. Do analysts prefer RELV or IBIO? iBio has a consensus target price of $5.00, suggesting a potential upside of 435.62%. Given iBio's stronger consensus rating and higher probable upside, analysts clearly believe iBio is more favorable than Reliv' International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Reliv' International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00iBio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to RELV or IBIO? In the previous week, iBio had 2 more articles in the media than Reliv' International. MarketBeat recorded 2 mentions for iBio and 0 mentions for Reliv' International. Reliv' International's average media sentiment score of 0.00 beat iBio's score of -0.50 indicating that Reliv' International is being referred to more favorably in the media. Company Overall Sentiment Reliv' International Neutral iBio Negative Is RELV or IBIO more profitable? iBio has a net margin of 0.00% compared to Reliv' International's net margin of -0.61%. Reliv' International's return on equity of -1.89% beat iBio's return on equity.Company Net Margins Return on Equity Return on Assets Reliv' International-0.61% -1.89% -1.31% iBio N/A -73.15%-45.51% Do insiders & institutionals believe in RELV or IBIO? 8.0% of Reliv' International shares are held by institutional investors. Comparatively, 7.9% of iBio shares are held by institutional investors. 31.2% of Reliv' International shares are held by company insiders. Comparatively, 0.6% of iBio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better earnings & valuation, RELV or IBIO? Reliv' International has higher revenue and earnings than iBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReliv' International$35.06M0.13-$440KN/AN/AiBio$400K45.87-$24.91M-$1.74-0.54 Which has more risk & volatility, RELV or IBIO? Reliv' International has a beta of -0.1, suggesting that its share price is 110% less volatile than the S&P 500. Comparatively, iBio has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. SummaryiBio beats Reliv' International on 8 of the 15 factors compared between the two stocks. Get Reliv' International News Delivered to You Automatically Sign up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RELV vs. The Competition Export to ExcelMetricReliv' InternationalPharmaceutical Preparations IndustryStaples SectorNASDAQ ExchangeMarket Cap$4.40M$736.37M$16.01B$10.14BDividend YieldN/A4.84%3.01%4.60%P/E Ratio-22.911.1718.2725.98Price / Sales0.1326.6447.00181.13Price / Cash44.5319.5614.9560.44Price / Book0.406.686.136.29Net Income-$440K-$4.13M$679.99M$271.07M Reliv' International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RELVReliv' InternationalN/A$2.52flatN/AN/A$4.40M$35.06M-22.9191IBIOiBio1.6767 of 5 stars$0.88+6.0%$5.00+466.4%-51.1%$17.35M$375K-0.51100Short Interest ↑Gap DownETHZFlag Ship AcquisitionN/A$2.47+1.2%N/AN/A$14.92MN/A-0.167Gap UpHigh Trading VolumeNBYNovaBay Pharmaceuticals0.4106 of 5 stars$2.41+4.8%$0.85-64.7%+445.4%$14.04M$9.78M-0.0430Gap UpAEONAEON Biopharma3.1463 of 5 stars$0.74-1.3%$360.00+48,614.5%-98.5%$8.61MN/A4.115News CoverageShort Interest ↓Gap DownMTNBMatinas Biopharma0.1276 of 5 stars$1.62-1.2%N/AN/A$8.24MN/A-0.3330Short Interest ↑OBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050CPHIChina PharmaN/A$1.83+1.0%N/A-92.1%$5.96M$4.40M0.00250News CoverageNRBONeuroBo PharmaceuticalsN/A$0.68-1.8%N/A-80.7%$5.84MN/A0.0010GRAYGraybug VisionN/A$3.58+15.9%N/A-23.8%$5.62MN/A-2.0727High Trading VolumeAEZSAeterna ZentarisN/A$3.08+1.3%N/A-23.6%$5.52M$2.37M-0.2120 Related Companies and Tools Related Companies IBIO Competitors ETHZ Competitors NBY Competitors AEON Competitors MTNB Competitors OBSV Competitors CPHI Competitors NRBO Competitors GRAY Competitors AEZS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RELV) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina’s message to TrumpDid China just fire shots at America? Last week, in Tiananmen Square, China put on a chilling display of mi...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reliv' International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reliv' International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RELV Stock Alerts